Expanding the Promise of Immunotherapy

Leveraging elite immune responses to develop novel cancer immunotherapies


The Right People in the Right Place at the Right Time

Making advancements in immuno-oncology through strategic partnerships



April 4, 2017
OncoResponse to Present at BioCentury Future Leaders Conference

March 9, 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round